PEOPLE - QLT makes appointment:
This article was originally published in Clinica
Executive Summary
Biopharmaceutical company QLT (Vancouver, Canada) has appointed of Robert Butchofsky as president and CEO, effective immediately. My Butchofsky has been acting CEO since September 2005, before which he was working on the launch of QLT's flagship drug, Visudyne. The company has also just appointed Boyd Clarke as its new chairman.